Afternoon Report / IOOF get the go ahead (IFL, BOQ)

By Market Matters 10 December 19

IOOF get the go ahead (IFL, BOQ)

Market Matters Afternoon Report 10th December 2019

WHAT MATTERED TODAY

The local market initially bucked the overnight weakness seen in the US to chop around par for the morning before selling picked up at lunch to see the ASX200 close 0.34% lower, tracking back towards the 6700 level. The selling kicked in around the time China inflation data came in, with inflation running hot for November at 0.4%, above the 0.1% expected. Aussie house prices were also solid, with prices rebounding in the quarter by 2.4%, ahead of the 0.2% consensus. The Aussie battler caught a bid on the back of this, and the equity market found a seller.

Iron ore names were solid thanks to some strength in the commodity – word is China is targeting 6% growth and plans to run fiscal deficits for the near term to help build the economy. This is good for steel, and what is good for steel is good for iron ore. This helped materials top the sectors. REITs were the worst hit, falling 1%. Much of the selling here stems from fundies making room for yet another Centuria cap raise in their metro REIT (CMA).

Overall, the ASX 200 fell -23pts /-0.34% today to close at 6706. Dow Futures are trading marginally higher by +17pts/+0.06%

ASX 200 Chart

ASX 200 Chart

CATCHING MY EYE

IOOF (IFL) +0.64%; started the day strong thanks to APRA putting the final stamp of approval on the OnePath acquisition from ANZ. The prudential regulator spoke to IOOF’s progress towards managing conflicts in signing off on the deal. The rally was short lived – at one stage IFL was up 5.8%, only to close just marginally higher – with UBS pouring some cold water on the stock. The analyst there was keen to point out the headwinds facing the industry with additional compliance costs to be incurred. They did keep their outperform rating however. MM likes IFL and would be keen to buy around $7.50.

IOOF (IFL) Chart

Bank of Queensland (BOQ) -2.01%; the regional bank held their AGM today with the bank trading lower as they continue to talk down earnings. All banks have struggled with tightening margins and slow loan growth, but the regionals in particular are facing a difficult time on costs. BOQ talked to further tech investment crimping earnings in the short term but eventually helping the bank handle further regulation requirements and an increase in loans. They will be back in front of investors in February to unveil their new strategy. One positive takeaway was reiterating there were no anti-money laundering concerns at this stage. Not one for MM here.

Bank of Queensland (BOQ) Chart

Broker moves; 

·         Estia Health Raised to Buy at Moelis & Company; PT A$2.78

·         Estia Health PT Cut to A$2.40 from A$2.60 at Morgan Stanley

·         Newcrest Raised to Hold at Morningstar

·         Magellan Financial Cut to Sell at Morningstar

·         Bluescope Cut to Sell at Morningstar

·         OZ Minerals Cut to Underperform at RBC; PT A$9.50

·         MMS AU Raised to Neutral at Evans & Partners Pty Ltd

OUR CALLS

No changes to the portfolios today.

Major Movers Today

Have a great night

Harry & the Market Matters Team

Disclosure

Market Matters may hold stocks mentioned in this report. Subscribers can view a full list of holdings on the website by clicking here. Positions are updated each Friday, or after the session when positions are traded.

Disclaimer

All figures contained from sources believed to be accurate.  All prices stated are based on the last close price at the time of writing unless otherwise noted. Market Matters does not make any representation of warranty as to the accuracy of the figures or prices and disclaims any liability resulting from any inaccuracy. 

Reports and other documents published on this website and email (‘Reports’) are authored by Market Matters and the reports represent the views of Market Matters. The Market Matters Report is based on technical analysis of companies, commodities and the market in general. Technical analysis focuses on interpreting charts and other data to determine what the market sentiment about a particular financial product is, or will be. Unlike fundamental analysis, it does not involve a detailed review of the company’s financial position.

The Reports contain general, as opposed to personal, advice. That means they are prepared for multiple distributions without consideration of your investment objectives, financial situation and needs (‘Personal Circumstances’). Accordingly, any advice given is not a recommendation that a particular course of action is suitable for you and the advice is therefore not to be acted on as investment advice. You must assess whether or not any advice is appropriate for your Personal Circumstances before making any investment decisions. You can either make this assessment yourself, or if you require a personal recommendation, you can seek the assistance of a financial advisor.  Market Matters or its author(s) accepts no responsibility for any losses or damages resulting from decisions made from or because of information within this publication. Investing and trading in financial products are always risky, so you should do your own research before buying or selling a financial product.

The Reports are published by Market Matters in good faith based on the facts known to it at the time of their preparation and do not purport to contain all relevant information with respect to the financial products to which they relate. Although the Reports are based on information obtained from sources believed to be reliable, Market Matters does not make any representation or warranty that they are accurate, complete or up to date and Market Matters accepts no obligation to correct or update the information or opinions in the Reports. Market Matters may publish content sourced from external content providers.

If you rely on a Report, you do so at your own risk. Past performance is not an indication of future performance. Any projections are estimates only and may not be realised in the future. Except to the extent that liability under any law cannot be excluded, Market Matters disclaims liability for all loss or damage arising as a result of any opinion, advice, recommendation, representation or information expressly or impliedly published in or in relation to this report notwithstanding any error or omission including negligence.